Lindbrook Capital »

Altimmune shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $516 84 6.14

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Apple Stock (AAPL)
Golub Cap Bdc Cef (GBDC)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Amazon.com Stock (AMZN)
Powershares Qqq Tr Etf (QQQ)
Vertex Pharmaceuticals In Stock (VRTX)
Broadcom Stock (AVGO)
Vanguard Growth Etf Etf (VUG)

View all positions for Lindbrook Capital

Top funds holding Altimmune

BlackRock
Tang Capital Management
Susquehanna International
Geode Capital Management
Knoll Capital Management
Citadel Advisors
Bellevue Group
D. E. Shaw & Co
Dimensional Fund Advisors
Northern Trust
Jane Street
GSA Capital Partners
IMC-Chicago
Ensign Peak Advisors
Beirne Wealth Consulting Services

View all funds holding Altimmune